
What Is the Cost-Effectiveness of Pola-R-CHP in DLBCL?
The HemOnc Pulse
00:00
The Cost Effectiveness of a Novel Therapy for Lymphoma
Dr. Nikhil Firovengadam is a gastroenterologist and therapeutic endoscopist who primarily focuses clinically on pancreatic laryoninoscopy. Dr. Swehta works as an assistant professor at City of Hope in the lymphoma division. The project was to model a regimen that was novel and potentially would change the primary regimen used to treat DLBCL.
Transcript
Play full episode